CD BioSciences has announced its cytoskeleton-based tumor marker development service for cancer diagnosis.NEW YORK, UNITED STATES, April 26, 2024 / EINPresswire.com / — CD BioSciences, a comprehensive biotech company, has recently unveiled its latest and innovative service on cytoskeleton-based tumor marker development. This groundbreaking service…

Finance

Latest News

View More
© 2024 The Business Times. All Rights Reserved.